Company / Total Assets
Corbus Pharmaceuticals Holdings, Inc. Total Assets History
FY2015-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$66.3M
FY2022
5-year range
$47.0M / $107.7M
FY2018-FY2022
Trend
-38.4%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has fluctuated over the past 8 years, ranging from $13M in FY2015 to $108M in FY2021.
Based on SEC 10-K filings.
$66M in FY2022 with a 5-year CAGR of -0.2%.
Declined from $102M to $66M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +10.5%
- 5-Year CAGR
- -0.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -0.2%, indicating a declining trend.
- In FY2022, total assets decreased 38.4% year-over-year.
- Peak total assets was recorded in FY2021.
- Lowest total assets in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $66.3M | -38.4% |
| FY2021 | $107.7M | +5.3% |
| FY2020 | $102.3M | +108.2% |
| FY2019 | $49.1M | +4.6% |
| FY2018 | $47.0M | -29.8% |
| FY2017 | $67.0M | +274.4% |
| FY2016 | $17.9M | +38.9% |
| FY2015 | $12.9M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026